Immune Booster Cells Show Promise After Checkpoint Blockers in Liver Cancer
A Taiwanese preliminary study found that following a short course of immune checkpoint inhibitors with infusions of tumor-primed dendritic cells ...
A Taiwanese preliminary study found that following a short course of immune checkpoint inhibitors with infusions of tumor-primed dendritic cells ...
Researchers have combined patient-derived pancreatic tumor organoids with a deep learning algorithm called OrganoIDNet to automatically track in real time ...
A large Japanese cohort study finds that 41% of patients with autoimmune GFAP astrocytopathy develop cognitive impairment, with older age ...
Interventional oncology has evolved from image-guided biopsies into a fourth pillar of cancer care, combining ablation, embolization, and immunotherapy synergies ...
A new review in Annals of Hematology details how molecular profiling and a growing arsenal of targeted and immune-based therapies ...
A genomic study of 841 melanoma patients at NYU Langone Health found that underrepresented minority patients experienced significantly more immune ...
A new review synthesizes clinical trial evidence showing that combining radiotherapy with immune checkpoint inhibitors can dramatically boost response rates ...
The China Anti-Cancer Association's 2026 CONS guideline provides a GRADE-based framework for assessing risk, preventing, and treating neutropenia across chemotherapy, ...
Researchers have built a whole-body computational model that simulates how vaccination site, timing, and tumor-derived suppression shape anti-cancer immune responses, ...
A 2023 review from Fudan University documents how Chinese clinical trials and single-cell omics studies are transforming the treatment and ...
A retrospective Chinese study finds that adding the PD-1 inhibitor tislelizumab to paclitaxel-carboplatin chemotherapy and bevacizumab significantly improves response rates, ...
Researchers built a five-gene PANoptosis-based risk model and nomogram that predict survival, immune landscape, and treatment sensitivity in esophageal cancer ...
A new review in Materials Today Bio proposes a bottleneck-first framework for evaluating antigen delivery platforms in therapeutic cancer vaccines, ...
A sweeping new review maps how the epithelial guardian protein MUC1, and especially its MUC1-C signaling subunit, is hijacked by ...
In a remarkable advancement in the field of oncology, particularly in the treatment of hepatocellular carcinoma (HCC), recent research has ...
Cholangiocarcinoma (CCA) is an aggressive malignancy originating from the biliary epithelium, and its complex tumor microenvironment (TME) plays a crucial ...
A groundbreaking study has recently emerged, spotlighting the significant role that gut microbiota play in reshaping the immune microenvironment within ...
In a groundbreaking advancement poised to reshape regenerative medicine and immunotherapy, a team of researchers has successfully developed a highly ...
Recent advancements in cancer immunotherapy have highlighted the crucial role of tumor microenvironment components, particularly M2 macrophages, in shaping the ...
In the rapidly evolving landscape of immunotherapy, a groundbreaking approach is emerging that holds transformative potential for pediatric autoimmune diseases. ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.